Background: Nocturia is one of the commonest nonmotor symptoms in Parkinson's disease (PD) and has a significant impact on quality of life both for patients and their carers. There exists a relation between nocturia and poor sleep quality, falls, and institutionalization. Nocturia may manifest as a result of reduced functional bladder capacity or nocturnal polyuria; however, most often the cause is multifactorial. Disorders of circadian rhythm regulation are known to occur with sleep disturbances in PD may also contribute to nocturia. Methods and Results: In this review, an overview of the assessment and management of nocturia in patients with PD is presented. History taking, medication review, and a bladder diary form the cornerstone of the evaluation. Urinalysis, ultrasonography, and urodynamic studies help to assess the cause for lower urinary tract symptoms and exclude concomitant pathologies, such as bladder outlet obstruction. Antimuscarinic medications are the first-line treatment for the overactive bladder; however, caution is needed when using these medications in individuals predisposed to cognitive impairment. Desmopressin is effective for managing nocturnal polyuria. Conclusions: An individualized approach is recommended to optimize the management of nocturia in PD.Parkinson's disease (PD) is characterized predominantly by motor complaints, consisting of bradykinesia, rigidity, and rest tremor and gait disturbances. However nonmotor symptoms (NMS) commonly accompany these motor symptoms.1 Lower urinary tract (LUT) symptoms are common in PD and include storage symptoms (urinary urgency, increased daytime frequency, and nocturia, with or without incontinence) and voiding symptoms (urinary hesitancy, interrupted or poor stream, and double voiding). 2,3 The prevalence of LUT symptoms varies between 38% and 71%, 4,5 and its severity increases with progression of PD, paralleling other manifestations of autonomic dysfunction.
6Urinary symptoms are an important cause for morbidity in PD, having a devastating impact on quality of life, and have been recognized by Parkinson's UK as one of the top 10 priority areas for research in PD.
7Using a standardized validated questionnaire of NMS, the NMS Quest, nocturia was found to be the most common LUT symptom, reported by more than 60% of participants.8 Nocturia was, in fact, reported to be the commonest NMS reported in this study. The cause for nocturia in PD is poorly understood; however, it is likely to be multifactorial. [9][10][11] We review the pathophysiology of nocturia in PD and principles for management.
Prevalence of Nocturia in PDQuestionnaire based studies generally report a high prevalence of nocturia, with figures ranging between 76% 12 and 86%, 13,14 though one study reported a prevalence of only 34.6%. 15 In a study of 115 PD patients using a questionnaire on pelvic organ functions, Sakakibara et al. reported nocturia (or nighttime frequency) in 53% of men and 63% of women with PD.16